Skip to main content

Memantine Hydrochloride Extended-Release Capsules Shortage

Last Updated: May 26, 2016
Status: Resolved

Reason for the Shortage
    • Actavis states the reason for the shortage of Namenda XR capsules was manufacturing delay.
    • There are several other manufacturers of memantine immediate release tablets and these were not affected by the shortage.
Available Products
    • Namenda XR oral capsule, Actavis, 14 mg, 30 count, NDC 00456-3414-33
    • Namenda XR oral capsule, Actavis, 14 mg, 90 count, NDC 00456-3414-90
    • Namenda XR oral capsule, Actavis, 14 mg, unit-dose 100 count, NDC 00456-3414-63
    • Namenda XR oral capsule, Actavis, 21 mg, 30 count, NDC 00456-3421-33
    • Namenda XR oral capsule, Actavis, 28 mg, 30 count, NDC 00456-3428-33
    • Namenda XR oral capsule, Actavis, 28 mg, 90 count, NDC 00456-3428-90
    • Namenda XR oral capsule, Actavis, 28 mg, unit-dose 100 count, NDC 00456-3428-63
    • Namenda XR oral capsule, Actavis, 7 mg, 30 count, NDC 00456-3407-33
    • Namenda XR oral capsule, Actavis, Titration Pack 28 count, NDC 00456-3400-29

Estimated Resupply Dates

    • Actavis has all Namenda XR presentations available.

Updated

Updated May 26, 2016 by Leslie Jensen, PharmD, Drug Information Specialist. Created February 19, 2014 by Jane Chandramouli, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer